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Since first introduced, the endovascular repair of
infrarenal aortic aneurysms has been gaining increas-
ing acceptance as favorable early outcome reports
increase in numbers and feasibility reports prolifer-
ate, which expand the anatomic indications for this
approach.1-8 Despite the strong enthusiasm for this
new method,9-12 the consistent findings of high
postprocedure endoleak rates (up to 21%) appear to
represent a real and poorly understood prob-
lem.3,10,13-15 The data presented from the
Endovascular Technologies and Medtronic trials at
the Federal Drug Administration panel this summer
indicated up to 48% endoleak rates on early com-
puted tomographic (CT) scan follow-up. Although
great concern has been expressed over persistent
anchoring site (type I) endoleaks (particularly prox-
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Objectives: The purpose of this study was (1) to find out whether preoperative inferior
mesenteric artery (IMA) patency (on radiographic imaging) predicts IMA-related
endoleaks after endovascular repair of infrarenal abdominal aortic aneurysms, (2) to
determine feasibility of measuring aneurysm sac pressures in patients with endoleaks,
and (3) to report early evidence of effective endovascular obliteration of IMA endoleaks.
Methods: We studied 76 consecutive cases of infrarenal aortic aneurysms that were
repaired with an endovascular approach (March 1998–April 1999).
Results: There were 13 (17%) endoleaks persistent 30 days after the procedure. Eleven
(85%) of these 13 were IMA-related endoleaks, which were documented with selective
superior mesenteric artery angiography. The preoperative finding (on computed tomo-
graphic scan) of a patent IMA does not always predict an IMA-related endoleak, but
results in a statistically and clinically significant higher ratio of patients with IMA-relat-
ed endoleaks in the immediate postoperative period (24% versus 3%, P < .035). In eight
of the 11 patients with persistent IMA-related endoleaks, measurement of intra-
aneurysm sac pressures was possible, and six of these patients had systemic pressures
within the excluded aneurysm sac. Nine (82%) of 11 IMA-related endoleaks were suc-
cessfully obliterated by means of selective IMA embolization.
Conclusions: Many endoleaks are caused by a patent IMA, and this can result in persistence
of systemic pressure within the aneurysm sac. The preoperative finding (on computed
tomographic scan) of a patent IMA is a predictor of increased rates of IMA endoleaks, and
IMA endoleaks can be successfully obliterated through endovascular procedures, after
endovascular abdominal aortic aneurysm repair. (J Vasc Surg 2000;32:777-88.)
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imal endoleaks), little is known about the signifi-
cance of type II endoleaks (related to the inferior
mesenteric artery [IMA], lumbar arteries, and other
collateral vessels).16 A significant percentage of
endoleaks (related to anchoring sites or collateral
vessels) appears to spontaneously disappear after
variable periods of follow-up.3 Therefore, the time
interval that defines a persistent endoleak that trig-
gers concern varies widely among investigating cen-
ters. Even after the endoleak forms a thrombus and
is no longer detectable on CT scan, it is unknown
whether this occurrence eliminates transmitted pres-
sure through the unexcluded thrombus to the
aneurysm sac. If there remains transmitted systemic
pressure to unexcluded aneurysmal aorta, one might
anticipate that, analogous to an unrepaired throm-
bosed aneurysm, the risk of rupture would remain.
Because the risk of aneurysm rupture in different
types of endoleaks is unknown, investigators at dif-
ferent centers have arbitrarily opted to follow up
patients with different types of endoleaks for time
intervals ranging from days to months to more than
1-year periods.3 It has been assumed by many who
are currently investigating this new minimally inva-
sive procedure that only persistent proximal
endoleaks carry the ongoing risk of aneurysm rup-
ture. However, an increasing number of published
and unpublished anecdotal reports indicate that
patients may rupture their abdominal aortic
aneurysms (AAAs) after what has been thought to be
successful endovascular aneurysm exclusion, and
even with documented aneurysm size reduction.13,17
Not all reports are clearly connected to just proximal
anchoring site endoleaks. For this main reason, care-
ful long-term follow-up has been advocated by many,
as we learn more about the effectiveness and durabil-
ity of this new method of aneurysm repair.16,18-23
Recently, an in vitro study suggested that even a small
collateral vessel (0.410 mm) could maintain systemic
pressure within an excluded aneurysm sac model.24
In this study, we focused on IMA-related type II
endoleaks. Our goal was to begin to characterize the
incidence and clinical significance of IMA-related
type II endoleaks. We tried to answer specific ques-
tions of relevance to both doctors and patients: (1)
To what extent does preoperative IMA patency, on
radiographic imaging, represent a predictor of post-
operative IMA endoleaks after endovascular repair of
infrarenal aortic aneurysms? (2) Can an IMA
endoleak transmit systemic pressure to the aneurysm
sac? (3) Can an IMA endoleak be safely and success-
fully obliterated through the endovascular approach
after primary stent grafting? (4) Alternatively, is
there reason to attempt preoperative IMA emboliza-
tion, when the vessel is seen to be patent by preop-
erative imaging modalities?
METHODS
Patients. The current work is a retrospective
analysis of prospectively collected data that included
our first consecutive 76 cases performed at our cen-
ter from March 1998 to April 1999 in patients who
underwent endovascular repair of infrarenal AAAs as
part of an ongoing phase II multicenter clinical trial.
All patients were enrolled after written informed
consent was obtained in accordance with the guide-
lines and approved by our Institution Review Board
and the Federal Drug Administration.
Indications and graft designs. As depicted in Fig
1, A, 46% of patients were treated as part of an “emer-
gency compassionate” group. These were patients
with a severe medical comorbidity that precluded open
repair; they also had unfavorable aneurysm anatomy
that disqualified them for enrollment in the established
low- and high-risk standard protocols. Unfavorable
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Fig 1. Diagrams showing the distribution of patients
within the various clinical protocols: (A) indications and
(B) graft designs.
B
A
aneurysm anatomy included infrarenal aortic
aneurysm neck length less than 15 mm, angulated
neck greater than 45 degrees, trapezoidal or conical
necks, dilated necks (> 28 mm), and narrow and tor-
tuous iliac arteries that required a surgical conduit for
access or required extensive angioplasty before access.
Thirty-three percent and 21% of patients were enrolled
in the low- and high-risk protocols, respectively. These
patients’ medical comorbidity was acceptable for
potential open repair only in the low-risk group, but
not in the high-risk group. Both the low- and high-risk
standard protocols only included patients whose
aneurysm anatomy was favorable for endovascular
repair. The anatomy and extent of the aneurysm dic-
tated the type of repair, after a specific philosophy that
aims at complete exclusion of flow through aneurys-
mal parts of the aorta, the iliac arteries, or both. When
aorto–uni-iliac devices were used, the clinical protocols
required embolization of the contralateral common
iliac artery (and ipsilateral hypogastric artery, depend-
ing on aneurysm extent). When the distal anchoring
site was the external iliac artery, we adopted a protocol
of preoperative embolization of the ipsilateral
hypogastric artery. The rationale for this approach was
to eliminate any potential type II endoleak that may be
related to flow from the hypogastric artery, around the
distal anchoring site and back into the aneurysm sac,
with outflow through sac collaterals such as lumbar
arteries or the IMA. In general, such planned preoper-
ative embolizations were performed as separate staged
procedures. The types of endoprostheses implanted
are summarized in Fig 1, B, and included 59 modular
(Talent; Medtronic/World Medical Manufacturing
Corp, Sunrise, Fla) devices and 17 unitary (Ancure;
Guidant/Endovascular Technologies, Menlo Park,
Calif) devices.
Preoperative determination of IMA patency.
IMA patency was defined as visualization of this ves-
sel in communication with the aneurysm as seen by
use of preoperative imaging, which included a con-
trast CT angiography, conventional contrast arteri-
ogram, and in selected patients (those with chronic
renal insufficiency), magnetic resonance angiogra-
phy (MRA). Diagnostic magnetic resonance imag-
ing and MRA substituted CT scan/contrast arteri-
ogram in five patients because of an elevated creati-
nine level. All radiographic studies were retrieved
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Fig 2. Intraoperative completion arteriograms showing
(A) no evidence of endoleak and (B) evidence of an
endoleak.
Table I. IMA patency by preoperative angiography
versus postoperative IMA endoleaks
IMA endoleak No endoleak Total*
IMA patent by 5 16 21
angiography
IMA not patent 5 43 48
by angiography
Total† 10 59 69
% of patients with 50% 27%
preoperative patent 
IMA by angiography
χ2 Test P = .279
*Two patients with anchoring site endoleaks were excluded.
†Five patients not studied by angiography preoperatively were
excluded. (One patient with IMA endoleak and four patients
without IMA endoleak.)
A
B
and independently rereviewed in a blinded fashion
by an expert radiologist.
Assessment for endoleaks. In the operating
room after the device was implanted, the proximal
and distal anchoring sites were individually studied
with the use of antegrade and retrograde arteri-
ograms to identify anchoring site endoleaks. If such
an anchoring site problem was identified, further
ballooning, stenting, or adding of covered exten-
sions was performed until the operating surgeon was
thoroughly satisfied that an anchoring site endoleak
was completely ruled out. At this point, a power
injection completion antegrade arteriogram, with
delayed imaging, was performed. An endoleak was
defined as any visualized contrast (including faint
blush) filling the aneurysm sac outside of the stent
graft (Fig 2). Postoperative CT scans (150 cc of iod-
inated contrast material at 4 mL/s with spiral 3-mm
cuts with a pitch of 2) were performed before dis-
charge and at 1 month of follow-up. Views obtained
from these CT scans included predynamic, dynamic,
and delayed contrast images that were reviewed for
the presence or absence of endoleaks, with both the
printed films (Fig 3) and a three-dimensional (3-D)
work station. Some patients were studied postoper-
atively with ultrasound scanning, which can be use-
ful in documenting the presence or absence of an
endoleak19 as shown in Fig 4. However, we
observed early in our experience that in many
patients, the postoperative ultrasound scan study
was suboptimal or inconclusive.
Determination of endoleak etiology. Further
diagnostic and therapeutic arteriograms were per-
formed in patients with 30-day persistent endoleaks,
which were aimed at clearly identifying the source of
the endoleak. In our experience, CT scan and ultra-
sound scan modalities were insufficient for accurately
determining the type of endoleak present. Because
most centers now agree that a type I endoleak may
essentially represent an untreated AAA, it is our phi-
losophy that in the setting of an endoleak that has per-
sisted for 30 days, one needs to rule out the presence
of a type I endoleak. With this rationale, selective and
supraselective arteriograms were used to accurately
diagnose the source of all endoleaks noted to persist
beyond 30 days after endovascular AAA repair. When
technically feasible, this modality was also used thera-
peutically to obliterate endoleaks. These arteriograms
were undertaken as a methodic and objective evalua-
tion. First, an antegrade arteriogram by way of a prox-
imally placed 5F pigtail catheter was performed; we
specifically looked for proximal anchoring site
endoleaks. Anterior-posterior and lateral intra-arterial
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Fig 3. Postoperative CT scan showing (A) no evidence of
endoleak, (B) evidence of endoleak of unspecified etiolo-
gy (selective angiogram demonstrated this patient to have
an IMA-related endoleak), and (C) an anchoring site
endoleak identified by helical 3-D reconstruction CT
angiogram. E, Endoleak; L, lumen.
A
B
C
digital subtraction aortograms were performed with
the pigtail positioned at the proximal stent graft
anchoring site; we filmed at three frames per second
and continued until contrast was completely washed
out of the arterial and venous systems. Similar arteri-
ograms were repeated with the pigtail moved to the
graft-to-graft attachment sites. Retrograde arteri-
ograms by way of distal femoral sheaths were then
performed; we looked for distal anchoring site
endoleaks. After anchoring site or graft-to-graft
endoleaks were excluded, selective superior mesen-
teric artery (SMA) and hypogastric artery angiograms
were performed; we looked for endoleaks related to
collateral circulation (IMA or lumbar arteries, respec-
tively). At this time, a microcatheter was advanced
into the aneurysm sac (when technically feasible), and
pressure measurements were obtained. Also at this
time, selective embolization of the collateral vessel
causing the endoleak was performed when feasible, as
described below.
Treatment of type II endoleaks and measure-
ment of aneurysm sac pressures. In the investiga-
tion and treatment of IMA-related endoleaks, a 4F
or 5F catheter was placed at the proximal neck of the
SMA, and an external coaxial tracker (3F, 150 cm)
microcatheter (Fast Tracker; Boston Scientific,
Natick, Mass) was used to cannulate the middle colic
artery. The Tracker catheter was advanced through
the middle colic and IMA into the aneurysm sac.
After a hand-injected digital run was performed to
confirm the origin of the endoleak, intrasac pressure
measurements were made and compared with sys-
temic arterial pressure. They were measured nonin-
vasively at the level of the brachial arteries. The high
resistance of the catheter system and the anatomic
tortuosity of the collateral vessels en route to the
IMA, in most cases, precluded measurement of sys-
tolic, diastolic, and pulse pressures. In those
patients, mean pressure was therefore recorded for
comparison with mean systemic pressure.
The microcatheter was then withdrawn to the
proximal portion of the IMA, where microcoils were
deployed until radiographic evidence of stasis of
blood flow was obtained. Subsequent SMA arteri-
ograms were performed to confirm elimination of
the endoleak. Postembolization CT scans were also
performed to examine the aneurysm sac and confirm
the complete obliteration of the endoleak.
Statistical analysis. The relationship between
patients who had postoperative IMA endoleaks and
those who had evidence of a patent IMA by use of
preoperative imaging was studied by calculating sen-
sitivity, specificity, positive predictive value, negative
predictive value, and accuracy for each of the preop-
erative imaging modalities alone and in combina-
tions. Contingency tables were formulated and ana-
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Fig 4. Postoperative ultrasound scans showing (A) no evidence of endoleak and (B) evidence of
endoleak (arrow).
Table II. IMA patency by preoperative CT scan
versus postoperative IMA endoleaks
IMA endoleak No endoleak Total*
IMA patent by CT 9 29 38
IMA not patent by CT 1 31 32
Total† 10 60 70
% of patients with 90% 48%
preoperative patent 
IMA by CT
χ2 Test‡ P = .035 
*Two patients with anchoring site endoleaks were excluded.
†Four patients not studied by CT preoperatively were excluded.
‡Statistically significant difference (P < .05).
lyzed with a χ2 test. For these calculations, a 30-day
persistent endoleak related to the IMA (as con-
firmed by selective SMA angiography) was defined
as the gold standard of clinically significant IMA
patency in this patient population. All calculations
were performed with Primer of Biostatistics for
Windows 95 version 4.0 (Stanton A Glantz;
McGraw-Hill, Inc, Health Professions Division,
Pittsburgh, Pa; part no. 864181-0).
RESULTS
There were 13 (17%), 30-day persistent endoleaks
on postoperative CT scans at 1 month of follow-up.
Only five of these were noted in the operating room
on completion power injection arteriogram. The
remaining eight were undetected on the operating
room completion arteriogram. Conversely, 17 patients
with evidence of endoleak on completion arteriogram
in the operating room subsequently had no evidence
of endoleak on follow-up CT scans (Fig 5).
With the use of a CT scan plus standard and
selective angiography, 11 (85%) of 13 endoleaks per-
sisting at 30 days were confirmed to be related to col-
lateral circulation from the IMA into the aneurysm
sac (Fig 6, A). Lumbar arteries and branches of the
hypogastric arteries were often identified as sources
of outflow by injecting contrast directly into the
aneurysm sac through the same catheter used to
measure aneurysm sac pressure (Fig 7). There were
one proximal and one distal anchoring site endoleaks
(2.6% overall, 15% of all endoleaks). During the
course of this study, all patients with persistent flow
through the aneurysm sac were noted to have patent
lumbar arteries that served as egress vessels (includ-
ing the two patients with type I endoleaks), but ante-
grade flow into the aneurysm sac from a lumbar
artery source was not seen in this series of patients,
despite thorough evaluation that included selective
hypogastric artery arteriography. Also, anchoring site
endoleaks were repaired with covered stent graft
extensions as secondary endovascular procedures.
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Fig 5. Graft indicating number of patients with endoleaks
seen on completion arteriogram in the operating room
versus those patients with 30-day persistent endoleaks
visualized on follow-up CT scan.
Fig 6. Postoperative selective SMA angiography for (A)
diagnosis and (B) treatment of IMA endoleak. Arrow in A
points to contrast blush into aneurysm sac immediately
next to IMA, which fills retrograde through SMA collat-
erals. Arrow in B points to microcoils within the IMA,
now obliterating the contrast blush. E, Endoleak.
The IMA patency revealed through preoperative
angiogram and preoperative CT scan in patients with
and without postoperative IMA endoleaks is shown in
Tables I and II. Angiography revealed a preoperative
patent IMA in 50% of patients with an IMA-
associated endoleak. Only 27% of those patients with-
out an endoleak had an angiographically patent IMA.
This difference did not reach statistical significance
(Table I). Ninety percent of patients with an IMA-
related endoleak had a preoperative patent IMA
detected through CT scan versus only 48% of those
without an endoleak (Table II). This difference was
statistically significant. Twenty-four percent of
patients with a patent IMA detected through preop-
erative CT scan versus only 3% of those without a
patent IMA (detected through preoperative CT scan)
had IMA-related type II endoleaks that persisted at 30
days after stent graft repair of their AAAs (P < .05).
The sensitivity, specificity, predictive value, and
accuracy of the imaging modalities were calculated,
with the assumption that a 30-day persistent IMA
endoleak was the gold standard measure of a clini-
cally relevant IMA patency, to determine whether
one can predict postoperative IMA-related
endoleaks on the basis of IMA patency revealed
through preoperative imaging (Table III).
Sensitivity was best for the CT scan alone at 90%.
Specificity and accuracy were best for concurring
readings on CT scan and angiogram. The negative
predictive value was high with all single and combi-
nation imaging modalities (highest for CT scan
alone at 97%; Table III). The positive predictive
value and accuracy were uniformly low (Table III).
In eight of the 11 patients with an IMA-related
30-day persistent endoleak, the aneurysm sac pres-
sure was measured with the use of a catheter tech-
nique as depicted in Fig 7 and Table IV. Six of these
patients had systemic pressures within the aneurysm
sac. In the remaining three patients, the measure-
ment of sac pressure was not technically feasible
because of vessel caliber and tortuosity, which result-
ed in an inability to advance the microcatheter.
Selective embolization of the IMA was possible
with subsequent obliteration of the IMA-related
endoleaks in nine of 11 patients (Fig 6, B). In the
other two patients, one endoleak thrombosed spon-
taneously at 1 month of follow-up, and one patient
died of severe preexisting hepatic dysfunction. All
patients with subselective embolization of the IMA
had angiographic resolution of the endoleaks and
negative 1-month follow-up CT scans (Fig 8).
In this series, all surviving patients are free of
endoleaks; 13 (17%) of 76 patients have required sec-
ondary endovascular procedures aimed at obliterat-
ing 30-day persistent endoleaks. One patient (1%)
had postoperative colonic ischemia that required
colon resection. This patient had a history of colon
resection, had a patent IMA revealed through preop-
erative imaging, and required an aortoiliac device for
aneurysm repair. This patient also underwent staged
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Table III. Ability of preoperative study to predict postoperative IMA endoleak
Preoperative study documenting IMA patency
CT and angiography CT, angiography, or MRA (any preoperative 
CT Angiography (concurring reading) imaging indicating IMA patency)
Ability of preoperative study 
to predict postoperative IMA 
endoleak by
Sensitivity (%) 90 50 50 91
Specificity (%) 52 73 81 41
Positive predictive value (%) 24 24 31 21
Negative predictive value (%) 97 90 91 96
Accuracy (%) 57 70 77 49
Table IV. Intra-aneurysm sac pressure in patients
with IMA endoleaks
Intra-aneurysm sac pressure* 
Endoprosthesis design compared with system pressure†
Aortoiliac Systemic
Aortoiliac Systemic
Bifurcated Systemic
Bifurcated 1⁄2 systemic
Bifurcated Systemic
Aortoiliac Systemic
Bifurcated 1⁄2 systemic
Bifurcated Systemic
*Aneurysm sac pressures were measured with trans-IMA catheter
pushed into the sac, a translumbar catheter pushed into the sac,
or a catheter negotiated into sac directly between the proximal
anchoring site and the aortic wall.
†Systemic pressures were measured at an upper extremity.
embolization of both hypogastric arteries. A patent
IMA without any evidence of postoperative colon
ischemia was seen in three other patients repaired
with aortoiliac devices; none had prior colon surgery.
DISCUSSION
The current work has shown that a significantly
higher proportion of patients whose preoperative
CT scan demonstrates a patent IMA had postopera-
tive IMA-related endoleaks compared with those
whose preoperative CT scan did not show a patent
IMA (9 [24%] of 38 vs 1 [3%] of 32; P < .05).
Similarly, a significantly higher proportion of
patients with an IMA-related endoleak had a patent
IMA visualized with preoperative CT scan compared
with patients without an endoleak (9 [90%] of 10 vs
29 [48%] of 60; P = .035) (Table II). The preoper-
ative identification of a patent IMA on arteriogram
did not have a similar predictive value (Table III).
Therefore, the preoperative identification of a patent
IMA on CT scan was associated with a statistically
and clinically significantly higher proportion of
patients with postprocedural type II endoleak
(which included inflow from the IMA and outflow
through patent lumbar arteries).
In a clinical sense, however, a useful significant
predictor of postoperative type II endoleak could
discriminate which of the patients with a patent IMA
would be most likely to have an IMA-related type II
endoleak (ie, there would be a clinical test with high
positive predictive value and high accuracy). An
analysis of the preoperative imaging studies alone
and in combination demonstrates that the positive
predictive value and accuracy are not sufficiently
high enough to discriminate clinically between
patients in such groups; that is, in patients for whom
the preoperative imaging indicates a patent IMA,
most will not have an IMA-related endoleak (Table
III). For these reasons, we do not advocate preoper-
ative interventions (eg, embolization of the IMA)
based on the preoperative imaging studies, because
this would result in many unnecessary intervention-
al procedures. This recommendation is further
strengthened by our success with the postoperative
endovascular obliteration of IMA endoleaks by
means of selective embolization (in those patients
with persistent endoleaks).
Although it might be considered intuitive or
“self-evident” that patients with nonpatent IMAs
should not have IMA-related endoleaks, it is reas-
suring that the data confirm this expected finding,
while demonstrating the constraints of the overall
incidence of false positives and false negatives and
the global sensitivity, specificity, and accuracy of the
preoperative imaging studies as they demonstrate
the status of the IMA. Because radiographic imaging
data depend on technical aspects of the performance
of the study as well as the subjective interpretation of
the radiologist, we believe that the statistical analysis
performed in this study bears significant relevance to
the question of whether a clinician can trust such
data for the purposes of patient information, predic-
tions, or both as to the potential trouble with IMA-
related endoleak. Although it is true that fewer than
a quarter of patients who had a radiographically
patent IMA went on to have an IMA-related
endoleak, it is also true that a statistically and clini-
cally significant higher ratio of patients with a patent
IMA (radiographically) went on to have an IMA
endoleak when compared with the group of patients
who had a radiographically nonpatent IMA.
We have also identified in this series that intraoper-
ative endoleaks visualized on completion arteriogram
are not necessarily predictive of postoperative persis-
tent endoleaks visualized on follow-up CT scans.
Because the standard nonselective aortogram does not
appear to be the best method for detecting endoleaks
and because many collateral branches may thrombose
spontaneously between the completion arteriogram
and the first postoperative CT scan, we were not sur-
prised to find little correlation between the endoleaks
seen in the operating room completion arteriogram
and those seen on postoperative CT scans.
With the measurements of aneurysm sac pressure
in patients who had IMA-related endoleaks, we have
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Fig 7. Radiograph showing catheter within the aneurysm
sac during measurement of intra-aneurysm sac pressure
after endovascular repair in a patient with a 30-day persis-
tent endoleak.
established feasibility of this technique and demon-
strated that a significant number of patients with an
IMA endoleak continue to have systemic pressure
within the aneurysm sac. The presence of the micro-
catheter within the IMA may actually lead to alter-
ations in the detected pressure within the aneurysm
sac (by virtue of the microcatheter partially occluding
flow within the patent IMA). We believe that this may
in fact account for the lower pressure recorded in the
two patients and the overall decreased pulse pressure
noted within the aneurysm sac. However, this is only
speculation, and the data available are insufficient to
determine with certainty what might be the etiology
or clinical significance of the measured pressures.
Further studies are clearly warranted on this subject.
Moreover, in view of the fact that intrasac pressures
were not measured in any patient in whom there was
not a postoperative endoleak, one cannot be absolute-
ly certain that the patent IMA is the only cause of the
high intrasac pressure. It is unlikely that the high
intrasac pressures were maintained by patent lumbar
arteries in these studied patients, given the angio-
graphic evidence, as discussed later. Alternatively, it
might be possible that the pressure may be actually
transmitted through the fabric wall into the aneurysm
sac. The current study was not designed to answer
these difficult questions, which would require the
measurement of sac pressures in patients without an
endoleak and with various types of endoleaks. The
current study represents the first feasibility report.
Further studies designed to answer these important
physiologic questions are certainly indicated.
In this series we have noted an overall 30-day per-
sistent endoleak rate of 17%, which is within the range
of what others have reported,3,5,9,25-29 but we have a
preponderance of type II endoleaks, all of which have
been IMA-related endoleaks (IMA identified as
inflow, lumbar arteries visualized and likely to repre-
sent outflow, as discussed below). We would have
expected a higher rate of anchoring site endoleaks,
given that 46% of patients enrolled had extreme unfa-
vorable anatomy for endovascular repair, but this was
not seen possibly because of our preference for
suprarenal fixation and the preponderant use of mod-
ular devices that allow for easy intraoperative repair of
detected anchoring site leaks. This distribution of
endoleak etiology has not been frequently noted by
other investigators. One may postulate that such a dif-
ference reflects a sampling variability related to a dif-
ferent set of patients with a differing range of
aneurysm anatomic features, to differences in the
types of endoprosthesis used, or to differences in fix-
ation choice (most of our patients were repaired with
suprarenal bare-spring fixation). However, it is more
likely that our methodic and extensive study designs
aimed at clearly identifying the exact endoleak inflow
source account for our findings. This rigorous, objec-
tive approach that we have pursued for the identifica-
tion of endoleak etiology has not been previously
undertaken. Most earlier reports have not used post-
operative selective angiography in the pursuit of
endoleak etiology. Most authors have relied on post-
operative CT scans and ultrasound scanning in the
evaluation of postoperative endoleaks.3,18-23
In many patients, the anatomic variability of
where the collateral vessels enter and exit the
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Fig 8. Summary of the follow-up and treatment in all patients with 30-day endoleaks.
aneurysm sac precludes an exact localization of the
endoleak inflow source when only CT or ultrasound
scan imaging is used, even with the use of dynamic
spiral CT angiography with 3-D reconstruction; how-
ever, in one patient we were able to clearly demon-
strate the endoleak source using this latter modality
(Fig 3, C). Standard antegrade anterior-posterior and
lateral aortography was also limited in many cases, in
terms of clearly localizing the source of endoleaks.
One case (a proximal endoleak) was diagnosed by the
use of this latter modality without need for further
selective images. However, most cases required selec-
tive angiography to clearly identify the endoleak
inflow source. In some patients with CT scan evi-
dence of an endoleak, no obvious contrast blush was
noted with standard aortography. In these cases,
selective arteriograms revealed the small but definite
contrast extravasation into the aneurysm sac. In all
cases, a source of egress from the sac was noted
through small lumbar or hypogastric artery branches.
In our series, lumbar arteries, branches from the
hypogastric arteries, or accessory renal arteries were
not seen to fill the aneurysm sac antegrade as a pri-
mary source of a type II endoleak. Because preoper-
ative angiogram and CT scan showed these branch-
es to be patent in many patients, we believe they
were small enough to have thrombosed after stent
grafting. When patent, they did not show antegrade
flow into the aneurysm sac but appeared to serve as
egress vessels. Similarly, many patients with a patent
IMA revealed through preoperative imaging did not
show an IMA-related endoleak, presumably because
of thromboses of this vessel after stent grafting.
In all cases where the IMA produced an ante-
grade contrast blush in the aneurysm sac, lumbar
artery branches were identified as egress vessels on
delay filming. As a matter of traditional radiograph-
ic convention, we have attributed the cause of the
endoleak to the source of inflow (in our series, the
IMA). Other groups have reported a higher rate of
lumbar artery–related type II endoleaks. Thus, one
may question whether some of the endoleaks
observed in our series have inflow through the lum-
bar arteries. However, the selective hypogastric arte-
riograms fail to indicate antegrade flow from lumbar
artery branches in the aneurysm sac. The type II
endoleaks noted were identified only on selective
SMA and IMA arteriogram. It would be unlikely
that contrast dye injected under pressure through a
catheter located in the IMA would diffuse through
the aneurysm sac and then flow against systemic
pressure into the lumbar arteries. This contrast
would then follow retrograde, against systemic pres-
sure, into the patent lumbar arteries and drain
through the venous system only if the lumbar arter-
ies represented a low-pressure system acting as an
outflow for the endoleak. We are certain that the
collective data obtained from the thorough selective
and subselective arteriography were sufficient to pre-
cisely identify the nature and source of the endoleak
at hand in each patient. Therefore, it was concluded
that in the series reported, the type II endoleaks
observed thus far show inflow from the IMA and
outflow through the lumbar arteries. To the extent
that flow through an endoleak mandates both inflow
and outflow (from a high-pressure system to a low-
pressure system), the patent lumbar arteries con-
tributed to the endoleak. However, selective
embolization of the IMA has resulted in successful
obliteration of the endoleak (with angiography and
CT scan) in all cases thus far.
The patient who had colonic ischemia had a
patent IMA preoperatively revealed through CT
scan and angiogram. Stent grafting resulted in
thrombosis of this vessel, which for this patient must
have been essential for distal colon perfusion
because his prior colon surgery compromised other
natural collaterals. The endovascular approach pre-
cludes the intraoperative decision of reimplanting
the IMA on the basis of direct colon inspection, and
therefore, such decision making becomes part of the
preoperative planning. For this reason, evaluation of
the preoperative imaging modalities with which one
looks for IMA patency plus consideration of any
prior colon surgery becomes essential in determin-
ing stent graft design and feasibility for the endovas-
cular approach. This is becoming increasingly
important as the current enthusiasm for expanding
the applications for this new technology continues
to grow.6-8,21,23,30
Although most agree that anchoring site
endoleaks represent a failure to successfully repair the
aneurysm with the use of the endovascular method,
the significance of type II endoleaks remains
unknown, and there is no consensus for a standard
treatment.3,30-33 Some have reported success with
embolization of the feeding collateral vessel responsi-
ble for the endoleak,3,33 whereas others have advo-
cated embolization of the aneurysm sac itself.26,32
This latter method continues to carry the question of
whether systemic pressure can be transmitted
through a clot to the aneurysmal aortic wall. In some
cases the option has been to observe without treat-
ment depending on feasibility and success of sec-
ondary procedures.3 In Zarins et al’s report,3 9% of
patients continued to have an endoleak at 6 months
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of follow-up, but all endoleaks were no longer seen
on CT scan at 15 months of follow-up. They report
no aneurysm ruptures during follow-up and evidence
of aneurysm size decreasing from 6.5 to 5.0 cm in
one patient at 1 year of follow-up despite persistence
of the endoleak. Other authors have also noted a lack
of aneurysm growth on short-term follow-up despite
persistent endoleaks.34 However, it is difficult to
interpret what this means for a patient, because some
authors report aneurysm rupture despite successful
stent grafting and aneurysm rupture in the presence
of aneurysm size decreases.13,17,18,35 Is it possible
that, to some degree, we are rediscovering the natur-
al history of untreated or partially treated AAAs?
In our series, one patient who had a symptomatic
aneurysm (pain and tenderness) continued to have
symptoms until a type II endoleak was successfully
treated by coil embolization of the IMA. Another
patient with an endoleak (of unknown etiology) at
discharge died suddenly after collapsing with abdom-
inal pain at home, before the 1-month follow-up CT
scan. This patient had a 7.5-cm aneurysm with min-
imal thrombus within the sac. Schurink et al’s24 in
vitro model elegantly demonstrated that every
endoleak, even a very small one, caused more than
systemic diastolic pressure within the aneurysm sac.
Our data have shown that IMA endoleaks can result
in systemic pressure within the aneurysm sac. For
these reasons we have chosen the approach that the
aneurysm is not completely repaired until the patient
is free of endoleaks. Recognizing that it may take
days before all the small collaterals thrombose and
knowing that, in fact, a significant number do throm-
bose at 30 days of follow-up, we have chosen 1
month as our follow-up interval before elective sec-
ondary endovascular procedures aimed at diagnosis
and potential treatment. Our primary concern and
clinical rationale for the 30-day selective arteriogram
for persistent endoleaks were any abilities to rule out
anchoring site endoleaks. Our premise has been that
anchoring site endoleaks may behave like untreated
AAAs. Thirty days represent an arbitrary interval that
lies within what one might consider to be a reason-
able waiting period for elective open repair (to date,
the standard method of treatment). However, one
might stipulate, on the basis of our experience, that
this interval may need to be shortened in patients
with symptomatic aneurysms or those with large
aneurysms and little thrombus within the aneurysm
sac. Others may contend that this interval is too
aggressively short and may choose to follow up these
patients for longer periods, provided the aneurysm
does not progressively expand.
In summary, a significant number of type II
endoleaks are caused by a patent IMA. IMA endoleaks
can transmit systemic pressure to the aneurysm sac.
Selective SMA angiography appears to be the most
effective method to identify IMA endoleaks. The pre-
operative CT scan can be useful in predicting the risk
of IMA-related endoleaks, but its accuracy and positive
predictive value are not sufficiently high enough to
advocate preemptive IMA embolization. Selective coil
embolization of the IMA can safely and successfully
obliterate persistent IMA endoleaks after aortic stent
grafting. The physiology and clinical significance of
endoleaks needs further study.
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